Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C
- 27 October 2006
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (12) , 1789-1793
Abstract
Background: Clearance of hepatitis C virus (HCV) is attributed to host cellular immune responses, in which T helper cells play a critical role. The purpose of the present paper was therefore to study the serial changes of serum soluble markers released from T helper 1 (Th1) and 2 (Th2) and their correlations with treatment responses in chronic hepatitis C patients receiving interferon‐α plus ribavirin for 24 weeks.Methods: Serum markers (soluble CD26 and CD30 levels) of T helper cells were quantified before and 6 months after combination therapy in 33 chronic hepatitis C patients and in 20 healthy controls.Results: Compared to healthy controls, chronic hepatitis C patients had significantly lower serum soluble CD26 levels before (140.4 ± 63.9 ng/mLvs200.6 ± 60.3 ng/mL,P < 0.0001) and after (115.9 ± 32.9 ng/mLvs200.6 ± 60.3 ng/mL,P < 0.0001) combination therapy. The level was even lower in those with non‐sustained virologic response (non‐SVR; 139.0 ± 50.9 ng/mLvs117.7 ± 40.3 ng/mL,P = 0.039). In contrast, soluble CD30 levels at 6 months after combination therapy were significantly lower in patients with SVR than those with non‐SVR (6.4 ± 3.5 U/mLvs10.4 ± 5.4 U/mL,P = 0.021).Conclusion: Chronic hepatitis C patients have a weak Th1 response as reflected by lower soluble CD26 levels and the levels are even lower in non‐sustained responders. In sharp contrast, downregulation of Th2 response with serial changes of soluble CD30 level is associated with successful treatment of HCV infection.Keywords
This publication has 25 references indexed in Scilit:
- Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infectionHuman Immunology, 2003
- Interaction between the Hepatitis C Virus and the Immune SystemSeminars in Liver Disease, 2000
- Changes in Plasma Soluble CD26 and CD30 during Pregnancy: Markers of Th1/Th2 Balance?Gynecologic and Obstetric Investigation, 2000
- SOLUBLE CD30 SERUM LEVEL IN HCV-POSITIVE CHRONIC ACTIVE HEPATITIS: A SURROGATE MARKER OF DISEASE ACTIVITY?Cytokine, 2000
- Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsetsJournal of Allergy and Clinical Immunology, 1997
- Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus ChronicityHepatology, 1997
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infectionJournal of Hepatology, 1994
- Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infectionJournal of Hepatology, 1994
- A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral ProteinsScience, 1990